Update README.md

README.md

@@ -14,11 +14,12 @@ widget:
   - Temsirolimus 25 MG/1 ML Intravenous Solution
   - C3537356
   - C1949367
-  - 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML
-    / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza
-    B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine,
-    B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent
-    2013-2014 Formula]
+  - >-
+    0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03
+    MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML
+    / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML /
+    influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML
+    Prefilled Syringe [Fluzone Quadrivalent 2013-2014 Formula]
 - source_sentence: spastic ataxia type 2
   sentences:
   - ZPLD2P gene
@@ -39,10 +40,14 @@ widget:
   - CD 3 color developer, sulfate, hydrate (2:3:1)
 - source_sentence: Albendazol
   sentences:
-  - N-(p-(((2,4-diamino-5-methyl-6-quinazolinyl)methyl)amino)benzoyl)-L-glutamic acid
+  - >-
+    N-(p-(((2,4-diamino-5-methyl-6-quinazolinyl)methyl)amino)benzoyl)-L-glutamic
+    acid
   - C0699923
   - C0130494
   - SKF-92058
+base_model:
+- pankajrajdeo/UMLS-ED-Bioformer-16L-V-1
 ---
 
 # SentenceTransformer